{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-22-035802","form_type":"8-K","ticker":"ITIC","cik":"0000720858","company_name":"INVESTORS TITLE CO","filed_at":"2022-10-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:53.355517+00:00","generated_at":"2026-06-23T06:09:33.270952+00:00","sec_items":["1.01","3.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Investors Title extends poison pill to 2032, raises purchase price to $525","bullets":["Rights agreement extended from Oct 31, 2022 to Sep 30, 2032.","Purchase price increased from $220 to $525 per one-hundredth of a preferred share.","New 'Acting in Concert' definition triggers rights when parties act together to influence control.","Other technical and conforming changes made to the agreement."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-22-035802","json":"https://secwatch.observer/filing/0001140361-22-035802.json","markdown":"https://secwatch.observer/filing/0001140361-22-035802.md","text":"https://secwatch.observer/filing/0001140361-22-035802.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/720858/000114036122035802/0001140361-22-035802-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/720858/000114036122035802/brhc10041897_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T06:09:33.270952+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}